KL1333
KL1333, a derivative of β-lapachone, is an orally available NAD+ modulator. KL1333 reacts with NAD (P) H:quinone oxidoreductase 1 (NQO1) as a substrate, resulting in increases in intracellular NAD+ levels via NADH oxidation. KL1333 improves energy metabolism and mitochondrial dysfunction in MELAS fibroblasts. KL1333 protects against Cisplatin-induced ototoxicity in mouse cochlear cultures[1][2].
Product Specifications
CAS Number
1800405-30-4
UNSPSC
12352005
Target
Mitochondrial Metabolism; Quinone Reductase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/nqo1-activator-1.html
Purity
99.94
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(C1=C2N=C(C(C)C)N1)C(C3=C2C=CC=C3)=O
Molecular Formula
C14H12N2O2
Molecular Weight
240.26
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
STEAP4 (STEAP Family Member 4, Metalloreductase STEAP4, STAMP2, TIARP, TNFAIP9)
Glra1 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse)
